Approach to the bleeding child

Pediatric Clinics of North America

Volumn 49, Issue 6, 2002, Pages 1239-1256

  Allen, Geoffrey A ^a   Glader, Bertil ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN;

ANAMNESIS; BLEEDING DISORDER; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD SMEAR; CHILD; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PROTHROMBIN TIME; REVIEW; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

BLOOD COAGULATION DISORDERS; CHILD; DIAGNOSIS, DIFFERENTIAL; ECCHYMOSIS; HEMORRHAGE; HEMOSTASIS; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION;

EID: 0036974438     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(02)00091-3     Document Type: Review

References (49)

1. Roberts HR, Tabares AH. Overview of the coagulation reactions. In: High KA, Roberts HR, editors. Molecular basis of thrombosis and hemostasis. New York: Marcel Dekker; 1995. p. 35-50.
2. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145:1310-1.
3. Macfarlane R. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 1964;202:498-9.
4. Kadir R. Women and inherited bleeding disorders: pregnancy and delivery. Semin Hematol 1999;36(Suppl 4):28-35.
5. Lee CA. Women and inherited bleeding disorders: menstrual issues. Semin Hematol 1999; 36(Suppl 4):21-7.
6. Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-9.
7. Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999;5:40-8.
8. Buchanan GR. Quantitative and qualitative platelet disorders. Clin Lab Med 1999;19:71-86.
9. Cook CS. Routine and special laboratory evaluation of coagulation. In: Stiene-Martin EA, Lotspeich-Steininger CA, Koepke JA, editors. Clinical hematology: principles, procedures, correlations. Philadelphia: Lippincott-Raven Publishers; 1998. p. 635-49.
10. De Caterina R, Lanza M, Manca G, et al. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 1994;84:3363-70.
11. Kerenyi A, Schlammadinger A, Ajzner E, et al. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thromb Res 1999;96:487-92.
12. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
13. Fressinaud E, Veyradier A, Sigaud M, et al. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyzer at high shear rates. Br J Haematol 1999;106:777-83.
14. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer PFA-100. Semin Thromb Hemost 1995;21:106-12.
15. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000;84:401-9.
16. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
17. Montgomery RR, Gill JC, Scott JP. Hemophilia and von Willebrand disease. In: Nathan DG, Orkin SH, editors. Nathan and Oski's hematology of infancy and childhood. 5th edition. Philadelphia: W.B. Saunders; 1998. p. 1631-59.
18. Montgomery RR, Kroner PA. von Willebrand disease: a common pediatric disorder. Pediatr Ann 2001;30:534-40.
19. Sadler JE, Mannucci PM, Bemtorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-74.
20. Wemer EJ. von Willebrand disease in children and adolescents. Pediatr Clin N Am 1996; 43:683-707.
21. Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-4.
22. Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type 1 von Willebrand disease: results of a patient survey. Haemophilia 2000;6:643-8.
23. Kouides PA. Menorrhagia from a haematologist's point of view. Part I: initial evaluation. Haemophilia 2002;8:330-8.
24. Blombäck M, Eneroth P, Landgren BM, et al. On the intraindividual and gender variability of haemostatic components. Thromb Haemost 1992;67:70-5.
25. Edlund M, Blomback M, von Schoultz B, et al. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996;53:234-8.
26. Anwar R, Miloszewski KJ. Factor XIII deficiency. Br J Haematol 1999;107:468-84.
27. Bauer KA. Rare hereditary coagulation factor abnormalities. In: Nathan DG, Orkin SH, editors. Nathan and Oski's hematology of infancy and childhood. 5th edition. Philadelphia: W.B. Saunders; 1998. p. 1660-76.
28. Stump DC, Taylor Jr FB, Nesheim ME, et al. Pathologic fibrinolysis as a cause of clinical bleeding. Semin Thromb Hemost 1990;16:260-73.
29. Mannucci PM, Tuddenham EGD. The hemophiliasfrom royal genes to gene therapy. N Engl J Med 2001;344:1773-9.
30. Bolton-Maggs PHB. Factor XI deficiency and its management. Haemophilia 2000; 6(Suppl 1):100-9.
31. Andrew M. Developmental hemostasis: relevance to newborns and infants. In: Nathan DG, Orkin SH, editors. Nathan and Oski's hematology of infancy and childhood. 5th edition. Philadelphia: W.B. Saunders; 1998. p. 114-57.
32. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985;106:351-9.
33. Watts RG, Castleberry RP, Sadowski JA. Accidental poisoning with a superwarfarin compound (brodifacoum) in a child. Pediatrics 1990;86:883-7.
34. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
35. Kelly DA, Summerfield JA. Hemostasis in liver disease. Semin Liver Dis 1987;7:182-91.
36. Beardsley DS, Nathan DG. Platelet abnormalities in infancy and childhood. In: Nathan DG, Orkin SH, editors. Nathan and Oski's hematology of infancy and childhood. 5th edition. Philadelphia: W.B. Saunders; 1998. p. 1585-630.
37. Blanchette VS, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 2000;37:299-314.
38. Di Paola J, Buchanan G. Immune thrombocytopenic purpura. Pediatr Clin N Am 2002;49:911-28.
39. Kelton JG, Bussel JB. Idiopathic immune thrombocytopenic purpura: an update. Semin Hematol 2000;37(3):219-21.
40. Medeiros D, Buchanan GR. Idiopathic thrombocytopenic purpura: beyond consensus. Curr Opin Pediatr 2000;12:4-9.
41. Castle V, Andrew M, Kelton J, Giron D. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749-55.
42. Zipursky A, Jaber HM. The haematology of bacterial infection in newborn infants. Clin Haematol 1978;7:175-93.
43. Ezekowitz A, Mulliken J, Folkman J. Additional corrections: interferon for hemangiomas of infancy [letter]. N Engl J Med 1995;333:595.
44. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001;112:851-62.
45. Blanchette VS, Rand ML. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol 1997;21:53-62.
46. Blanchette VS, Johnson J, Rand M. The management ofalloimmune neonatal thrombocytopenia. Bailliere's Best Pract Clin Haematol 2000;13:365-90.
47. Bussel JB, Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 2001;27(3):245-52.
48. Bussel J, Zabusky M, Berkowitz T, et al. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6.
49. Burk CD, Miller L, Handler SD, et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992;89:691-5.